STOCK TITAN

SI-BONE To Present at Piper Sandler 35th Annual Healthcare Conference on November 28, 2023

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary
SI-BONE, Inc. (Nasdaq: SIBN) announced its participation in the Piper Sandler Healthcare Conference in New York. The company's management will host a fireside chat on November 28, 2023, at 3:30 p.m. ET. Interested investors can register to listen to the conference call via a provided link. The webcast will be available on the company's website and archived for at least 90 days after the event.
Positive
  • None.
Negative
  • None.

SANTA CLARA, Calif., Nov. 14, 2023 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq: SIBN), a medical device company dedicated to solving musculoskeletal disorders of the sacropelvic anatomy, today announced that the company will be participating in the upcoming Piper Sandler Healthcare Conference in New York. Management will be hosting a fireside chat on Tuesday, November 28, 2023, at 3:30 p.m. Eastern Time / 12:30 p.m. Pacific Time.

Investors interested in listening to the conference call may do so by registering at this link: https://event.webcasts.com/starthere.jsp?ei=1643016&tp_key=96b15a8b6a. Live audio of the webcast will be available on the “Investors” section of the company’s website at: www.si-bone.com. The webcast will be archived and available for replay for at least 90 days after the event.

About SI-BONE, Inc.
SI-BONE (NASDAQ: SIBN) is a global leader in technology for surgical treatment of musculoskeletal disorders of the sacropelvic anatomy. Since pioneering minimally invasive SI joint surgery in 2009, SI-BONE has supported over 3,000 surgeons in performing a total of over 90,000 sacropelvic procedures. A unique body of clinical evidence supports the use of SI-BONE’s technologies, including two randomized controlled trials and over 120 peer reviewed publications. SI-BONE has leveraged its leadership in minimally invasive SI joint fusion to commercialize novel solutions for adjacent markets, including adult deformity, spinopelvic fixation and pelvic trauma.

For additional information on the company or the products including risks and benefits, please visit www.si-bone.com.

SI-BONE, iFuse Implant System and iFuse-TORQ are registered trademarks of SI-BONE, Inc. ©2023 SI-BONE, Inc. All Rights Reserved.

Investor Contact:
Saqib Iqbal
Sr. Director, FP&A and Investor Relations
investors@SI-BONE.com


FAQ

What is the date of the Piper Sandler Healthcare Conference?

The conference will take place on November 28, 2023.

Where will the conference be held?

The conference will be held in New York.

How can investors listen to the conference call?

Investors can register to listen to the conference call via the provided link.

For how long will the webcast be available for replay?

The webcast will be available for replay for at least 90 days after the event.

SI-BONE, Inc.

NASDAQ:SIBN

SIBN Rankings

SIBN Latest News

SIBN Stock Data

546.04M
37.66M
2.32%
104.51%
3.03%
Medical Devices
Surgical & Medical Instruments & Apparatus
Link
United States of America
SANTA CLARA